Anthropic Launches Drug Discovery Program for Diseases Big Pharma Ignores

Anthropic is launching its own drug development program targeting neglected diseases that commercial pharmaceutical companies consider unprofitable. Novartis CEO Vas Narasimhan believes AI could cut drug development time from twelve years to seven or eight and double the success rate from 8% to 16%. The initiative aims to fill a gap left by Big Pharma's profit-driven priorities.

More on this topic

🔬 Science AI speeds up drug discovery, but data quality is the key challenge MIT Technology Review · 3d ago 💻 Technology Anthropic launches Claude Science AI workbench and aims to develop its own drugs The Verge · 27d ago 💻 Technology Microsoft pitches homegrown AI models to Wall Street, directly rivalling OpenAI TechCrunch · 19h ago

More on this topic

🔬 Science AI speeds up drug discovery, but data quality is the key challenge MIT Technology Review · 3d ago 💻 Technology Anthropic launches Claude Science AI workbench and aims to develop its own drugs The Verge · 27d ago 💻 Technology Microsoft pitches homegrown AI models to Wall Street, directly rivalling OpenAI TechCrunch · 19h ago